Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$30,000.00
May 1, 2022
For-profit organization
RAPID ESA1 automation - Closure Platform
989527
Closure will be developing an automated Surface Risk Analysis module that will be capable of generating a Phase 1 Environmental Site Assessment report (ESA1) to an 80% completion level. Automation of this capability is expected to bring a 10 hour task down to sub 20 seconds.
$50,000.00
May 1, 2022
For-profit organization
Data Driven Knowledge Base for Mentorship Sessions
989546
This project optimizes the delivery of a mentoring program through data driven decisions.
$49,933.00
May 1, 2022
For-profit organization
Experimental Design: Development of a New Oyster Farming System
989563
A detailed research study will be done on the performance of the oysters in the new system with the collaboration of the firm's team. The experimental design and analysis are detailed.
$75,000.00
May 1, 2022
For-profit organization
CMS Go-to-Market Strategy
989625
To develop a product positioning, go-to-market, business scale-up strategy around the firm's CMS (Content Management System) platform.
$50,000.00
May 1, 2022
For-profit organization
Interpreting Patient Dialogs - Phase 1
989645
Doctors spend significant time using their electronic medical records (EMR) which limits their capacity to see patients and is a major contributor to doctor burnout and reduced patient satisfaction. The project aims to reduce the time doctors spend on charting, documentation, and other EMR tasks through automatic transcription and data processing with the ultimate goal of improving patient care.
$18,447.00
May 1, 2022
For-profit organization
IP Assist: Intellectual Property Strategy Engagement - phase 2
989669
The Project will support development of intellectual property capacity within the Firm
$150,000.00
May 1, 2022
For-profit organization
User Workflows for a Hybrid Integration Platform
989715
Develop streamlined user workflows to the Avato Hybrid Integration Platform that will simplify the process of connecting incompatible enterprise applications.
$153,300.00
May 1, 2022
For-profit organization
Integrated care coordination and reporting system for patient remote monitoring and engagement.
989808
Methods, architecture, and visualizations to combine patient reported outcomes, engagement/behavior metrics, and electronic health record data for better aggregate patient management, experience, and care coordination.
$25,000.00
May 1, 2022
For-profit organization
Product and Business Development of Novel Lipid Molecules for Drug and Vaccine Delivery.
989820
Rane Pharmaceutical has been actively involved in lipid manufacturing since 2016. During the recent Covid-19 pandemic, some novel lipid molecules became the key ingredient in developing mRNA and DNA-based vaccines against Covid-19 (SARS-CoV-2). There is also an increased interest in expanding the mRNA/DNA-based therapies into developing novel drugs for cancer and other rare diseases.
We plan to meet this increased demand by developing our large-scale production capacity and investing in additional resources (Scientist / Business development and Infrastructure) to create rare and novel lipids.
Dedicated business development staff will be hired to develop strategies to expand and reach international markets.
$200,000.00
May 1, 2022
For-profit organization
Predictive Flood Risk Management Platform
989852
Development of a predictive flood risk management platform to provide timely, actionable short term flood intelligence, allowing government, utilities, and corporations to take a more proactive approach to flood risk awareness.